Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens

About this trial

The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.

Eligibility criteria

Qualifiers

All patients examined in the echocardiography laboratory whose objective examination was a bicuspid valve of the aortic valve

Bicuspidia may be formerly known

Disqualifiers

Refusal to participate

Patients who had already undergone bicuspid surgery or ascending aorta before being examined at the echocardiography laboratory

Trial design

Treatments tested in this trial

  • Study the natural history of bicuspid

Treatment groups

No treatment groups listed